Education
About Us
Working with TipRanks
Follow Us
Ascelia Pharma AB (SE:ACE)
:ACE
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Gross Profit | kr 0.00 | kr -938.00K | kr -1.05M | kr -3.89M | kr -8.72M |
| Operating Income | kr -74.13M | kr -68.12M | kr -110.91M | kr -147.01M | kr -137.95M |
| EBITDA | kr -71.21M | kr -67.69M | kr -108.56M | kr -132.06M | kr -128.42M |
| Net Income | kr -76.25M | kr -80.03M | kr -109.29M | kr -131.22M | kr -125.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 49.86M | kr 75.26M | kr 21.86M | kr 149.56M | kr 261.60M |
| Total Assets | kr 111.94M | kr 140.92M | kr 87.07M | kr 218.57M | kr 333.49M |
| Total Debt | kr 1.04M | kr 25.40M | kr 1.06M | kr 484.00K | kr 1.66M |
| Net Debt | kr -48.82M | kr -49.86M | kr -20.80M | kr -149.07M | kr -259.94M |
| Total Liabilities | kr 12.47M | kr 61.98M | kr 12.74M | kr 37.71M | kr 25.66M |
| Stockholders' Equity | kr 99.47M | kr 78.94M | kr 74.33M | kr 180.86M | kr 307.83M |
| Cash Flow | |||||
| Free Cash Flow | kr -72.31M | kr -62.84M | kr -126.79M | kr -125.33M | kr -116.60M |
| Operating Cash Flow | kr -72.25M | kr -62.84M | kr -126.79M | kr -125.26M | kr -116.56M |
| Investing Cash Flow | kr -57.00K | kr 0.00 | kr 46.00K | kr -65.00K | kr -38.00K |
| Financing Cash Flow | kr 48.21M | kr 115.19M | kr -936.00K | kr -1.10K | kr 184.87M |